GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (STU:1ZL) » Definitions » Ending Cash Position

Zai Lab (STU:1ZL) Ending Cash Position : €691.7 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zai Lab Ending Cash Position?

Zai Lab's Ending Cash Position for the quarter that ended in Mar. 2024 was €691.7 Mil.

Zai Lab's quarterly Ending Cash Position declined from Sep. 2023 (€740.8 Mil) to Dec. 2023 (€725.6 Mil) and declined from Dec. 2023 (€725.6 Mil) to Mar. 2024 (€691.7 Mil).

Zai Lab's annual Ending Cash Position increased from Dec. 2021 (€853.9 Mil) to Dec. 2022 (€952.8 Mil) but then declined from Dec. 2022 (€952.8 Mil) to Dec. 2023 (€725.6 Mil).


Zai Lab Ending Cash Position Historical Data

The historical data trend for Zai Lab's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab Ending Cash Position Chart

Zai Lab Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 68.80 364.03 853.94 952.75 725.59

Zai Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 822.71 794.65 740.79 725.59 691.74

Zai Lab Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zai Lab's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=925.503+-199.914
=725.6

Zai Lab's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=727.963+-36.221
=691.7


Zai Lab Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zai Lab's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Zai Lab (STU:1ZL) Business Description

Traded in Other Exchanges
Address
4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Zai Lab (STU:1ZL) Headlines

No Headlines